Clinical Center; Notice of Closed Meeting

Issuing agencies

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 193 (Wednesday, October 7, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 193 (Wednesday, October 7, 2026)]
[Notices]
[Page 64155]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-20557]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Clinical Center; Notice of Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Board of Scientific 
Counselors of the NIH Clinical Center.
    The meeting will be closed to the public as indicated below in 
accordance with the provisions set forth in sections 552b(c)(4) and 
552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and 
evaluation of individual grant applications conducted by the Clinical 
Center, including consideration of personnel qualifications and 
performance, and the competence of individual investigators, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: Board of Scientific Counselors of the NIH 
Clinical Center.
    Date: October 26-27, 2026.
    Time: 9:30 a.m. to 1:00 p.m.
    Agenda: The Review and Discussion of the Department of 
Perioperative Medicine, Department of Transfusion Medicine, and 
Rehabilitation Medicine Department.
    Address: National Institutes of Health Clinical Center, Building 
10, 10 Center Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Leighton Chan, Ph.D., Chief Scientific Officer/
Scientific Director, National Institutes of Health, 10 Center Drive, 
Bethesda, MD 20892, (301) 496-4733, <a href="/cdn-cgi/l/email-protection#4a29222b24262f0a292964242322642d253c"><span class="__cf_email__" data-cfemail="c0a3a8a1aeaca580a3a3eeaea9a8eea7afb6">[email&#160;protected]</span></a>.

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.

    Dated: October 5, 2026.
Rosalind M. Niamke,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2026-20557 Filed 10-6-26; 8:45 am]
BILLING CODE 4167-05-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>